Aitziber Buqué

@FoxChaseCancer Our roster, features world leaders in this field, including our two Keynote presenters, Dr. Doug Green from St. Jude’s and Dr. Richard Kitsis from Albert Einstein College of Medicine. The event is free and but advanced registration is required at: secure3.convio.net/fccc/site/Cale…

Next October 31st, appropriate for the Halloween holiday 🎃, @FoxChaseCancer ’s Annual Immunity and Inflammation Symposium will focus on ☠️ death ☠️ - specifically, pathways by which cells die, and opportunities to exploit such pathways to treat cancers and other diseases. ⬇️

@FoxChaseCancer @TempleUniv #RadiationTherapy #Oncoimmunology

Excited to share our latest commentary published in Cancer and Metastasis Reviews where we discuss the recent work by @rweichselbaum on radiation-induced amphiregulin and metastasis. Thank you to @luciaborriell @rebeccamshulman Melissa McShane and Joshua E. Meyer (out of X)

@FoxChaseCancer @TempleUniv #RadiationTherapy

🚨 Exciting Opportunity Alert! 🚨 Are you passionate about understanding why cancer patients relapse and uncovering the secrets of tumor dormancy and metastasis? Join our dynamic lab @templemedschool and @FoxChaseCancer ✨ Please RT to spread the word! ✨

‼️Hi everyone, we are hiring again! We are looking for a motivated postdoc to join out working on iPSC-derived neurons and neurodegeneration using CRISPRi/a screens. Please Share! ‼️ #postdoc #postdocopportunities

🚨 We are hiring a Postdoctoral Researcher in Immunology & Microbial Pathogenesis! Join our team @WeillCornell in #NewYork to investigate how gut bacteria that escape their niche shape immunity and drive disease. Details below 👇 #Microbiome #Immunology #Immunotherapy

More than well deserved. Congratulations to my incredible mentor and colleague, Dr. Josh Meyer!

2025 ASTRO Fellow Spotlight Series Congratulations Joshua Meyer, MD from Fox Chase Cancer Center We look forward to recognizing you at #ASTRO25 ow.ly/JEkT50WAn9K @FoxChaseCancer

@ClaudiaGalassi9 @NatureCancer @deadoc80 @Giulia21P @WeillCornell Congratulations!! I'm so happy to see it out!

Finally out in @NatureCancer my first co-first author article on #breastcancer and #resistance to CDK4/6i. A special thank to @deadoc80 for his guidance and to @Giulia21P for inspiring me so much. Full manuscript here rdcu.be/eu8qw @WeillCornell

@Giulia21P @NatureCancer @deadoc80 @ClaudiaGalassi9 Congratulations! Amazing, beautiful, and tremendous work 💪🏼💪🏼

Our @NatureCancer paper is finally out!!! I'm over the moon! Many thanks to all the collaborators and a special thanks to @deadoc80 and @ClaudiaGalassi9

Check it out! Our last paper, where we studied the role of #necroptosis in HR+ #BreastCancer. Congratulations to all the authors! @ClaudiaGalassi9 @Giulia21P @Mbv26 @deadoc80 and Ai Sato @FoxChaseCancer @WeillCornell #Ikerkuntza #Zientzia @sitcancerECS @comunidadECUSA

@umncge Congratulations Vivek!

Congratulations to Vivek Verma! Learn more: hi.umn.edu/research/facul…

💬Nueva entrega de nuestras Mujeres referentes en la enfermedad celíaca. Hoy hablamos con @AinaCastellanos (investigadora Ikerbasque en la UPV-EHU, Bilbao) Puedes leer la entrevista completa en celiacosmadrid.org/novedades/noti… #EllasHacenHistoria #enfermedadcelíaca

Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients dlvr.it/TJZrTP

🚨Postdoctoral position in the Simon’s lab @acdc_temple @templemedschool. Project on studying lysosomal signaling dynamics in cardiac health and disease using targeted biosensors and dynamic super-resolution imaging. More info: nature.com/naturecareers/…

Yet another of our spotlights, now out in @TrendsinPharma, on a noval pharmacological platform for multimodal #cancer #immunotherapy. Kudos to Rafa (still unable to find his handle) and @Mbv26 for making this happnen, too! Free at authors.elsevier.com/a/1kJwqbg0kopDk!! @FoxChaseCancer